Skip to main content Skip to footer

Medicines Data - dm+d

The Medicines Data - dm+d team are responsible for updating and maintaining the dm+d (dictionary of medicines and devices). This includes manufacturer and supplier product and price information along with Drug Tariff entries for medicinal products.

Updates to dm+d can be emailed to nhsbsa.pippa@nhs.net or submitted through emc in-demand. All updates should be submitted to us at least 10 working days prior to their effective date. Effective date also known as launch date is required when submitting new products or packs. This date should reflect stock that is available in the warehouse and ready to be despatched to pharmacies. 

The dm+d data is extracted every Thursday evening and published on a Monday. Only changes with an effective date up to and including the Thursday will be published on the Monday. Once dm+d has been published nothing can be deleted. If your submission is incorrect you must contact us as soon as possible.

For appliances and CE marked devices go to Drug Tariff Part IX .

Prices

NHS trade price changes should be emailed to nhsbsa.pippa@nhs.net at least 10 working days prior to their effective date.

Price changes for ACBS (Advisory Committee on Borderline Substances) approved products, as listed in Drug Tariff Part XV, are to be approved by ACBS before being submitted to us.

How the price change mechanism works

As prices in the market are constantly changing, there is an agreed mechanism in place to increase and decrease the reimbursement prices for medicines. This is intended to take into account pharmacies having stock of certain products already on their shelves when a price change is first introduced.

PSNC keeps the proprietary and non-proprietary price change mechanisms under close review. Over the years, the current agreement has had a neutral effect on pharmacy contractors’ reimbursement given that prices decrease as well as increase from time to time.

Proprietary products

For proprietary preparations and Part VIIIA products where the price is based on a proprietary product (for example, most Part VIIIA Category C products), a price change up to and including the 8th of the month takes effect for prescriptions dispensed in the following month.

A price change after the 8th of the month will be applied for reimbursement purposes to prescriptions dispensed one month later. Part VIIIA Category C includes drugs that are not readily available as a generic. The price is based on a particular proprietary product, manufacturer or sometimes supplier.

For example, if the manufacturer’s list price for a proprietary product changed on 6 February, the new reimbursement price would apply to prescriptions dispensed in March. If a manufacturer’s list price changed on 15 February, the new reimbursement price would apply to prescriptions dispensed in April.

Generic products

For non-proprietary or generic products (excluding products in Part VIIIA, Category M) the reimbursement price change takes place one month earlier than proprietary products. Part VIIIA Category A includes popular generics, which are readily available. The price is based on a weighted average of the List Prices from 2 wholesalers and 2 generic manufacturers.

For example, if the manufacturer’s list price changed on 6 February, the new reimbursement price would apply to prescriptions dispensed in February. If a manufacturer’s list price for a generic drug changed on 15 February, the new reimbursement price would apply to prescriptions dispensed in March.

New or reinstated licensed medicinal products or packs

Requirements

  • Effective date of product or pack launch.
  • Final version of an SmPC (Summary of Product Characteristics) which includes completion of Part 8 and Part 9.
  • Product name as written in Part 1 of the SmPC. A copy of the packaging or artwork is also desirable.
  • The legal category.
  • The marketed pack size and how it's packaged, for example 28 tablets (2 packs of 14 tablets).
  • NHS trade price in pence, for example 100000 pence not £1000.
  • If the pack is only available in hospitals.
  • Unit GTIN code (previously known as EAN).

New ACBS approved products or packs

Products  on dm+d will only be indicated as ACBS approved or added to Drug Tariff Part XV on approval of your application from ACBS.

Requirements

  • Effective date of product or pack launch.
  • An image of the product that is going to be marketed.
  • Final version of the data sheet.
  • Product name as it appears on the packaging.
  • The marketed pack size and how it is packaged, for example 400ml (four x 100ml bottles).
  • NHS trade price in pence, for example 100000 pence not £1000.
  • If the pack is only available in hospitals.
  • Unit GTIN code (previously known as EAN).

New unlicensed products or packs

Requirements

  • Effective date of product or pack launch.
  • An image of the product that is going to be marketed.
  • Final version of the data sheet.
  • Product name as it appears on the packaging.
  • The marketed pack size and how it is packaged, for example 400ml (4 x 100ml) bottles.
  • NHS trade price in pence, for example 100000 pence not £1000.
  • If the pack is only available in hospitals.
  • Unit GTIN code (previously known as EAN).

Discontinued products or packs

When a product or pack is no longer being manufactured this will be indicated as discontinued and not deleted from dm+d.

Requirements

  • Effective date of discontinued product or pack.
  • Reason for discontinuation.
  • If the product has been divested to another manufacturer or supplier.
  • How much stock is still available.

Miscellaneous

Some changes to products or packs can have an impact on dm+d. The most common changes that affect dm+d include:

  • name changes
  • change in administration
  • change to excipients
  • change to storage conditions
  • change to nature and contents of container
  • GTIN changes

This is not a complete list. If you have any of these changes or any other that you think may affect dm+d, contact us by emailing nhsbsa.pippa@nhs.net   

Requirements

  • Effective date.
  • Nature of update.

emc in-demand

emc in-demand is a service provided by Datapharm. It allows manufacturers and suppliers to submit updates to their portfolio for PCDD and SCDD medicinal products electronically. You can view all the products we currently hold on dm+d, along with pack information, price and availability. 

If this is something you would be interested in contact Datapharm:

Email: servicedesk@datapharm.com

If you have a query in regards to a submission contact:

Email: nhsbsa.indemandppdsupport@nhs.net

Phone: 0191 203 5289